ENSYSCE BIOSCIENCES, INC.: 10-Q filed 2023-08-11
What ENSYSCE BIOSCIENCES, INC. reported in its quarterly report filed 2023-08-11 (fiscal Q2 2023): 33 published measures, 94 facts as tagged in accession 0001493152-23-027659.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2023-08-11
- Fiscal period
- fiscal Q2 2023
- Accession
- 0001493152-23-027659 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ENSYSCE BIOSCIENCES, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 6,357,623 | USD | |
| At 2022-12-31 | 5,885,052 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 2,564,816 | USD | |
| At 2022-12-31 | 9,914,704 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 4,119,016 | USD | |
| At 2022-12-31 | -3,714,444 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 3,829,482 | USD | |
| At 2022-12-31 | 3,147,702 | USD |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-06-30 | -6,715,461 | USD | 181 |
| 2022-01-01 to 2022-06-30 | -7,877,508 | USD | 181 |
Contract revenue excluding tax
Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 490,472 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 1,280,107 | USD | 181 |
| 2022-04-01 to 2022-06-30 | 207,471 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 810,569 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-06-30 | 7,397,241 | USD | 181 |
| 2022-01-01 to 2022-06-30 | -657,082 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 4,500 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | -115,363,208 | USD | |
| At 2022-12-31 | -110,931,063 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 2,274,113 | shares | 91 |
| 2023-01-01 to 2023-06-30 | 1,667,527 | shares | 181 |
| 2022-04-01 to 2022-06-30 | 141,615 | shares | 91 |
| 2022-01-01 to 2022-06-30 | 127,732 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 2,274,113 | shares | 91 |
| 2023-01-01 to 2023-06-30 | 1,667,527 | shares | 181 |
| 2022-04-01 to 2022-06-30 | 141,615 | shares | 91 |
| 2022-01-01 to 2022-06-30 | 127,732 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | -0.98 | USD/shares | 91 |
| 2023-01-01 to 2023-06-30 | -2.66 | USD/shares | 181 |
| 2022-04-01 to 2022-06-30 | -56.49 | USD/shares | 91 |
| 2022-01-01 to 2022-06-30 | -75.67 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | -0.98 | USD/shares | 91 |
| 2023-01-01 to 2023-06-30 | -2.66 | USD/shares | 181 |
| 2022-04-01 to 2022-06-30 | -56.49 | USD/shares | 91 |
| 2022-01-01 to 2022-06-30 | -75.67 | USD/shares | 181 |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-06-30 | 194,550 | USD | 181 |
| 2022-01-01 to 2022-06-30 | 698,013 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | -2,293,954 | USD | 91 |
| 2023-01-01 to 2023-06-30 | -4,855,188 | USD | 181 |
| 2022-04-01 to 2022-06-30 | -7,055,183 | USD | 91 |
| 2022-01-01 to 2022-06-30 | -11,857,986 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 5,855,073 | USD | |
| At 2022-12-31 | 5,299,169 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-06-30 | 1,497 | USD | 181 |
| 2022-04-01 to 2022-06-30 | 37,781 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 52,802 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 2,517,120 | USD | |
| At 2022-12-31 | 9,464,210 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 1,274,629 | USD | |
| At 2022-12-31 | 2,943,791 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 2,784,426 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 6,135,295 | USD | 181 |
| 2022-04-01 to 2022-06-30 | 7,262,654 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 12,668,555 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 1,643,726 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 3,439,742 | USD | 181 |
| 2022-04-01 to 2022-06-30 | 5,311,298 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 8,451,394 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 2,669,792 | shares | |
| At 2022-12-31 | 534,490 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 119,481,957 | USD | |
| At 2022-12-31 | 107,216,566 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 3,792,807 | USD | |
| At 2023-03-31 | -152,424 | USD | |
| At 2022-12-31 | -4,029,652 | USD | |
| At 2022-06-30 | -797,578 | USD | |
| At 2022-03-31 | 1,111,273 | USD | |
| At 2021-12-31 | -8,158,058 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 502,550 | USD | |
| At 2022-12-31 | 585,883 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | -2,239,302 | USD | 91 |
| 2023-01-01 to 2023-06-30 | -4,431,108 | USD | 181 |
| 2022-04-01 to 2022-06-30 | -7,923,120 | USD | 91 |
| 2022-01-01 to 2022-06-30 | -8,874,044 | USD | 181 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | -2,235,971 | USD | 91 |
| 2023-01-01 to 2023-06-30 | -4,432,145 | USD | 181 |
| 2022-04-01 to 2022-06-30 | -7,999,290 | USD | 91 |
| 2022-01-01 to 2022-06-30 | -9,665,976 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 1,140,700 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 2,695,553 | USD | 181 |
| 2022-04-01 to 2022-06-30 | 1,951,356 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 4,217,161 | USD | 181 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 11,030 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 16,448 | USD | 181 |
| 2022-04-01 to 2022-06-30 | 2,850 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 10,816 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 54,652 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 424,080 | USD | 181 |
| 2022-04-01 to 2022-06-30 | -867,937 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 2,983,942 | USD | 181 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 1,600 | USD | 181 |
Operating lease payments
Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-06-30 | 10,926 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-06-30 | -1,669,162 | USD | 181 |
| 2022-01-01 to 2022-06-30 | 2,746,933 | USD | 181 |
Inspect the source
- Entity
- ENSYSCE BIOSCIENCES, INC. / CIK 0001716947
- Captured
- 2026-09-21T17:24:39.335Z
- SEC response SHA-256
28573a09f81da1511239531464c03b2552a3554a684a233653f365b194b6ca0b
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001716947.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))